(4Z,7Z,10Z,13Z,16Z)-19,20-epoxydocosapentaenoic acid

Metabolite details

Identifier

OSXOPUBJJDUAOJ-MBYQGORISA-N

InChI Key

OSXOPUBJJDUAOJ-MBYQGORISA-N

IUPAC name

(4Z,7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-pentaenoic acid

Preferred name

(4Z,7Z,10Z,13Z,16Z)-19,20-epoxydocosapentaenoic acid

INN name

—

Synonym

19(20)-epoxy-4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid

ChEBI

CHEBI:72653

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Lipid mediators of inflammation in BALF 3-19 days after infection with influenza.
• Lipid mediators of inflammation in BALF 6-19 days after infection with influenza.
• Lipid mediators of inflammation in BALF 3-11 days after infection with influenza.
• Lipid mediators of inflammation in BALF 3-13 days after infection with influenza.
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)

Observed in differential profiles

• Control_vs_nsPEF_7_day
• Mock_18_days_vs_X31_19_days
• Mock_19d_vs_PR8_19d
• G1_Mock_11_day_vs_G5_PR8_11_day
• G1_Mock_11_day_vs_G5_PR8_11_day
• Mock_13d_vs_PR8_13d
• Normal_vs_Neural_Tube_Defect